- Home
- BKT vs OSUR Comparison
BKT vs OSUR Comparison
Compare BKT & OSUR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | BKT | OSUR |
|---|---|---|
| Founded | N/A | 2000 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Investment Bankers/Brokers/Service | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 337.5M | 295.7M |
| IPO Year | 1994 | 2000 |
Fundamental Metrics
Financial Performance| Metric | BKT | OSUR |
|---|---|---|
| Price | $10.44 | $3.88 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $3.00 |
| AVG Volume (30 Days) | 128.6K | ★ 453.7K |
| Earning Date | 01-01-0001 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $167,064,000.00 |
| Revenue This Year | N/A | $4.48 |
| Revenue Next Year | N/A | $7.76 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $10.16 | $2.08 |
| 52 Week High | $11.86 | $4.58 |
Technical Indicators
Market Signals| Indicator | BKT | OSUR |
|---|---|---|
| Relative Strength Index (RSI) | 48.01 | 47.27 |
| Support Level | $10.39 | $3.70 |
| Resistance Level | $10.67 | $4.29 |
| Average True Range (ATR) | 0.13 | 0.16 |
| MACD | 0.00 | -0.01 |
| Stochastic Oscillator | 36.20 | 38.98 |
Price Performance
Historical ComparisonAbout BKT BlackRock Income Trust Inc. (The)
Blackrock Income Trust Inc is a closed-end management investment company. Its investment objective is to manage a portfolio of high-quality securities to achieve both preservation of capital and high monthly income. The fund seeks to achieve its investment objective by investing at least 65% of its assets in mortgage-backed securities.
About OSUR OraSure Technologies Inc.
OraSure Technologies Inc is principally engaged in the development, manufacture, marketing, sale and distribution of (i) diagnostics products, and (ii) sample management solutions. It develops products and services that support diagnostic testing and healthcare data analysis, with a focus on improving access to healthcare. The company derives its revenues from the sale of diagnostics products and sample management solutions. Geographically, it generates the maximum revenue from the United States.